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ABSTRACT
Background Small studies suggest an association 
between ANCA- associated vasculitis (AAV) incidence and 
rurality, seasonality and socioeconomic deprivation. We 
examined the incidence of kidney biopsy- proven AAV and 
its relationship with these factors in the adult Scottish 
population.
Methods Using the Scottish Renal Biopsy Registry, all 
adult native kidney biopsies performed between 2014 and 
2018 with a diagnosis of granulomatosis with polyangiitis 
(GPA) or microscopic polyangiitis (MPA) were identified. 
The Scottish Government Urban Rural Classification was 
used for rurality analysis. Seasons were defined as autumn 
(September–November), winter (December–February), 
spring (March–May) and summer (June–August). Patients 
were separated into quintiles of socioeconomic deprivation 
using the validated Scottish Index of Multiple Deprivation 
and incidence standardised to age. Estimated glomerular 
filtration rate and urine protein:creatinine ratio at time of 
biopsy were used to assess disease severity.
Results 339 cases of renal AAV were identified, of which 
62% had MPA and 38% had GPA diagnosis. AAV incidence 
was 15.1 per million population per year (pmp/year). Mean 
age was 66 years and 54% were female. Incidence of 
GPA (but not MPA) was positively associated with rurality 
(5.2, 8.4 and 9.1 pmp/year in ‘urban’, ‘accessible remote’ 
and ‘rural remote’ areas, respectively; p=0.04). The 
age- standardised incidence ratio was similar across all 
quintiles of deprivation (p=ns).
Conclusions Seasonality and disease severity did not vary 
across AAV study groups. In this complete national cohort 
study, we observed a positive association between kidney 
biopsy- proven GPA and rurality.
INTRODUCTION
ANCA- associated vasculitis (AAV) is a disease 
that carries significant burden for patients 
and poses a management challenge for clini-
cians. AAV is often complicated by renal 
involvement as nephritic syndrome or rapidly 
progressive glomerulonephritis. The rarity of 
AAV means that, despite its clinical impor-
tance, epidemiological aspects have not been 
fully characterised.
Substantial progress has been made in 
understanding the pathophysiology and treat-
ment of AAV, yet it remains a significant cause 
Key messages
What is already known about this subject?
 ► There is a wide geographic variation in ANCA- 
associated vasculitis (AAV) with or without kidney 
involvement. Compelling evidence exists to impli-
cate genetic factors, although genetic predisposition 
on its own does explain the pathogenesis of this rare 
disease.
 ► Infectious triggers in the winter and allergies in the 
summer are linked to granulomatosis with poly-
angiitis (GPA).
 ► Other risk factors postulated in the development of 
AAV include UV light, solvents, silica and occupations 
such as farming. Consideration on socioeconomic 
factors on disease manifestation is limited.
What does this study add?
 ► Scotland has a relatively high rural population, and 
in this cohort, rurality but not socioeconomic factors 
and seasonality is associated with kidney biopsy- 
proven GPA.
How might this impact on clinical practice or 
further developments?
 ► Appreciating these environmental factors in renal 
AAV provides insight into the pathogenesis of this 
complex disease and directs health resources.
 ► Examining socioeconomic status offers useful ep-
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of end- stage kidney disease (ESKD) and mortality. The 
complex aetiology of AAV incorporates a variety of poten-
tial genetic, geographic and environmental contributing 
factors. Granulomatosis polyangiitis (GPA) and PR3 
positivity correlate with increasing latitudes and lower 
UV radiation.1 2 Worldwide, differences are seen across 
the distribution of disease phenotype. Studies show a 
higher incidence of microscopic polyangiitis (MPA) 
in the Southern Europe, while GPA is more common 
in Northern Europe.3 4 The UK and Japan has similar 
incidence of renal AAV; however, MPA is predominant 
in Japan.5 Another explanation for geographic pattern 
could be genetic variations. There is evidence genetic 
composition predispose to disease.6
Further postulations include infective ‘trigger’ or 
allergic mechanism contributing to seasonal manifes-
tation of disease.7 8 Raynauld et al suggested a seasonal 
trend in association with GPA but not the other vascu-
litides.9 Farming has been suggested as an explanation 
for the higher incidence of AAV seen in rural settings.10 
Exposure to silica, asbestos and solvents are some of the 
potential environmental triggers linked to AAV.10–13
Considering socioeconomic factors, several studies 
have explored a possible link between socioeconomic 
deprivation and incidence of AAV with mixed results.14–16 
We recently demonstrated a twofold increased risk of 
death in patients with primary glomerulonephritis living 
in relative socioeconomic deprivation.17 Chronic kidney 
disease (CKD) is more common in areas of social depriva-
tion18 and individuals living in these areas are more likely 
to progress to ESKD.19
The published studies exploring these possible environ-
mental triggers in AAV so far have been limited by small 
sample sizes, potential selection bias and limitations in 
ability to assess rurality and deprivation. The aim of this 
multicentre study was to explore the impact of rurality, 
seasonal variations and relative socioeconomic status on 
the incidence and presenting severity of kidney biopsy- 
proven AAV diagnosis in a complete national cohort 
using validated measures of rurality and deprivation.
METHODS
Patients and population
The Scottish Renal Biopsy Registry was used to obtain the 
study data. The Registry collects data from the nine Scot-
tish adult renal units on each kidney biopsy performed 
each year. As such, the registry has complete popula-
tion coverage (Scottish population 5.4 million).20 Using 
the registry, we identified all adults (age ≥16 years) who 
underwent native kidney biopsy across Scotland between 
2014 and 2018 inclusive with kidney biopsy- proven AAV. 
In any given patient, a diagnosis of MPA or GPA was made 
by the responsible renal physician, taking into account 
the systemic clinical syndrome and all investigations 
including ANCA serologies. All patients had histological 
evidence of renal involvement in a small- vessel, pauci- 
immune vasculitis. Only patients with a diagnosis of MPA 
(n=209) and GPA (n=130) were included in this study. 
Patients with ANCA- negative vasculitis and eosinophilic 
granulomatosis with polyangiitis were excluded. We 
restricted cases to kidney biopsy at diagnosis, excluding 
repeat biopsies.
Demographic data including age, sex and postcode 
at time of biopsy were extracted from the registry. Esti-
mated glomerular filtration rate (eGFR) and urine 
protein to creatinine ratio (uPCR) at time of biopsy were 
recorded. eGFR was calculated from serum creatinine 
using the Chronic Kidney Disease Epidemiology Collab-
oration(CKD- EPI) equation for patients with eGFR ≥60 
(15%). For cases reporting only urine albumin to creat-
inine ratio (12.1%), uPCR was calculated by multiplica-
tion of value by 1.37.21 22
Urban–rural classification
Urban–rural classification was defined using the Scottish 
Government Urban Rural Classification.23 On the three-
fold urban classification, urban (group 1) is defined as 
settlement of equal to and more than 3000 people. Acces-
sible rural (group 2) refers to a settlement of less than 
3000 people and within 30 min drive of a settlement of 
10 000 or more people. Remote rural (group 3) refers 
to a settlement of less than 3000 people and more than 
30 min drive to a settlement of 10 000 or more people.
Seasonality
Seasons were defined as applicable to the climate in 
Scotland: autumn (September–November), winter 
(December–February), spring (March–May) and 
summer (June–August).
Measures of socioeconomic deprivation
Using the Scottish Index of Multiple Deprivation 
(SIMD),24 patients were separated into quintiles of rela-
tive social deprivation. The SIMD is a model that meas-
ures relative deprivation across Scotland and is produced 
using Scottish Government Statistics, based on postcode 
and a weighted sum across seven domains (income, 
employment, health, education, skills and training, 
housing, geographic access and crime). Focusing on 
small areas in Scotland called ‘data zones’, 38 indicators 
of deprivation are explored and grouped into these seven 
domains. Each data zone is then ranked from 1 (most 
deprived) to 6976 (least deprived).
Using the 2016 SIMD rankings, datazones are separated 
into quintiles of deprivation. Quintile 1 representing 
most deprived to quintile 5 representing least deprived. 
The postcode of the patient at the time of biopsy was 
used to determine their deprivation quintile.
The mean age decreases with increasing quintiles of 
deprivation in Scotland and the incidence of AAV is known 
to increase with age. For this reason, we expressed the 
relationship between deprivation quintile and incidence 
of renal AAV as age- adjusted incidence and compared 
the incidences in each different quintile by calculating 
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in each age group according to Scottish Government 
data 2016,20 excluding the population under the age of 
16 years.
Statistical analysis
Baseline demographic and clinical data were summa-
rised by mean and SD or median and IQR or proportion, 
as appropriate.
The incidence of renal AAV in different rurality groups 
was compared using χ2 test as underlying population 
age distribution for these categories is not available and 
therefore comparisons could not be standardised.
For analysis of incidence of renal AAV by month and 
season, we calculated the mean and SD of the incidence 
in that month/season each year and compared these by 
one- way analysis of variance.
To compare the incidence of renal AAV in different 
quintiles of deprivation, the overall Scottish population 
age distribution within each SIMD quintile was obtained 
from published SIMD data 2016.20 Population under the 
age of 16 years was excluded. Patients were separated 
into two different age groups (<65 years and ≥65 years) 
for the purposes of analysis. The crude rate of disease 
was calculated by dividing number of cases observed 
during the study period in each quintile by SIMD popu-
lation estimates, per million patient years. This was stan-
dardised to the Scottish population age distribution for 
each quintile, and differences in standardised rates were 
calculated using the standard incidence ratio, with SIMD 
quintile 5 as the reference population. Statistical analysis 
was performed using GraphPad Prism. For all analyses 
p<0.05 was regarded as statistically significant.
RESULTS
Baseline demographics
There were 339 cases of new kidney biopsy- proven AAV 
in Scotland over the 5- year period. Overall incidence 
of kidney biopsy- proven AAV was 15.1 cases per million 
persons per year (GPA: 5.8 cases/million/year, MPA: 
9.3 cases/million/year) without significant variation 
between years. The demographic and clinical character-
istics of the patients by deprivation category are shown 
in table 1. Fifty- four per cent (n=183) were female with 
mean age of 66.2±13.1 years. At time of diagnosis, the 
mean eGFR was 32.0 (±27.2) mL/min/1.73 m2 and 
median uPCR was 146 mg/mmol (IQR 80–271). Five per 
cent (n=17) required haemodialysis at presentation and 
within 30 days of diagnosis by kidney biopsy. Diagnosis of 
MPA was more common than GPA (n=209 vs 130), and 
patients with MPA were significantly older at presentation 
(67 (±12.7) vs 63.5 (±13.6) years, respectively; p=0.02). 
Otherwise, these groups did not differ in mean eGFR 
(MPA 29.6±25.7 vs GPA 34.8±27.6 mL/min/1.73 m2, 
p=0.09) or median uPCR (MPA 142 IQR 76–278 vs GPA 
124 IQR 65–231 mg/mmol, p=0.15) at time of diagnosis. 
The proportion of missing data for uPCR and eGFR was 
22.8% and 6.0%, respectively. Six patients were excluded 
from the analysis of rurality and deprivation: three 
patients had registered postcodes outside Scotland and 
the other three patients had an unknown postcode.
Rurality
Of 334 patients included in the analysis of rurality (MPA 
n=205, GPA n=129), 79.9% (n=267) resided within an 
urban area, 13.5% (n=45) in an accessible rural region 
and 6.6% (n=22) in a remote rural area, which was not 
significantly different from the distribution across Scot-
land. Separating by type of AAV, the incidence of kidney 
biopsy- proven MPA in urban, accessible remote and 
rural remote areas was 9.2, 9.6 and 7.6 cases per million 
population per year, respectively (p=NS). The incidence 
of kidney biopsy- proven GPA, however, was significantly 
different in urban, accessible remote and rural remote 
areas at 5.2, 8.4 and 9.1 cases per million population per 
year, respectively (p=0.04) (figure 1).
Seasonal variation
The total number of cases occurring per month and 
during each season are shown in figure 2. This corre-
sponds to a mean of 3.5 (±1.0) new cases of kidney 














Male, n (%) 156 (46) 25 (42) 28 (40) 27 (44) 38 (54) 35 (48) N/A
Age±SD (years) 66±13 64±12 68±11 63±6 65±13 68±13 NS
MPA, n (%) 209 (62) 32 (54) 46 (66) 36 (58) 40 (57) 51 (71) N/A
GPA, n (%) 130 (38) 27 (46) 24 (34) 26 (42) 30 (43) 21 (29) N/A
uPCR* 146 (80–271) 99 (34–211) 127 (72–226) 147 (77–244) 147 (103–281) 138 (78–281) NS
eGFR* 32.0± 27.2 33.8 ± 28.9 31.7 ± 26.5 32.8 ± 25.9 30.7 ± 23.3 31.5 ± 23.2 NS
Six patients were excluded from deprivation analysis as postcode unavailable.
*Mean (SD) values eGFR (mL/min/1.73 m2) and median (IQR) of urine protein:creatinine ratio mg/mmol). Six patients were excluded from 
deprivation analysis.
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biopsy- proven MPA and 2.1 (±0.7) new cases of kidney 
biopsy- proven GPA per month each year, with no signif-
icant difference observed in month- to- month compar-
ison (p=ns). Seasonal analysis showed mean occurrence 
of 11.4 (±4.5) cases of kidney biopsy- proven MPA in 
autumn, 11.2 (±4.9) in winter, 10.6 (±1.5) in spring and 
8.6 (±1.9) in summer months each year (p=NS). In GPA, 
a mean of 6.6 (±2.7) cases occurred each autumn, 5.4 
(±3) each winter, 7.2 (±2.9) each spring and 6.4 (±0.9) 
each summer (p=NS). Overall, no significant differences 
in monthly or seasonal incidence across the 5 years of 
analysis were detected.
There was no significant difference in eGFR at biopsy 
during different seasons, although results varied widely. 
Similarly, no significant differences were noted in 
proteinuria at time of biopsy across seasons (table 2).
Association between socioeconomic status and diagnosis of 
AAV
To account for differing age distributions in different 
quintiles of deprivation, we adjusted for age. There was 
no significant difference in the incidence of renal biopsy 
proven AAV in different SIMD quintiles after adjusting 
for age (table 3A and B, figure 3). There was a trend 
towards GPA being less common when living in relative 
affluence, but this did not reach statistical significance.
There was no significant difference in the level of renal 
function or severity of proteinuria at diagnosis across 
deprivation categories (table 1): mean eGFR 33.8 (±28.9) 
mL/min/1.73 m2 vs 31.5 (±23.2) mL/min/1.73 m2 in the 
most deprived and least deprived areas, respectively, and 
median uPCR 99 mg/mmol ((IQR 34–211) vs 138 mg/
mmol (IQR 78–281)) in the most deprived and least 
deprived quintiles, respectively.
DISCUSSION
This is the first study to consider the role of rurality, 
seasonality and socioeconomic factors in the incidence 
of renal AAV over several years in a complete multicentre 
national cohort. We confirmed previous observations 
that MPA with renal involvment is more common than 
GPA in UK.25 We found that kidney biopsy- proven GPA, 
but not MPA, was associated with degree of rurality, with 
relatively more cases in rural areas when compared with 
urban. We observed no differences in the monthly or 
seasonal incidence of renal AAV. Furthermore, there was 
no significant association between socioeconomic status 
and incidence of renal AAV.
Few studies have previously considered the link 
between AAV incidence and rurality. Gonzalez- Gay et al26 
did not find any significant difference in AAV incidence 
between urban and rural populations in Spain. Published 
series from Australia and Germany however suggested 
higher incidences of primary vasculitis in rural areas.27 28 
Fifty- four per cent of vasculitides in the German cohort 
was giant cell arteritis. Therefore, results may not be 
representative for AAV. Looking at renal AAV, Anderson 
et al29 observed higher incidences of renal AAV in rural 
Northern Saskatchewan, Canada (16.5 cases pmp/year 
in rural areas compared with 6.1 pmp/year in urban 
areas), but this was a small study of only 33 cases of renal 
AAV. Exposure to farming (OR 2.3 (95% CI 1.2 to 4.6)) 
has previously been considered as a contributory factor, 
and our data support exploring this further.10 Agricul-
ture is one of the largest sources of employment in rural 
Scotland.30
Similarly, gardening is associated with GPA.31 The link 
between gardening and farming may relate to the expo-
sure of inhaled antigens from activities such as digging 
or mowing.
Rural communities have a culture of stoicism as a 
consequence of the self- sustainability that occurs with 
remote living. In rural north Scotland, longer distance to 
primary care services is associated with a lower likelihood 
Figure 1 Number of biopsies per million population 
per year for MPA and GPA within each rurality category, 
n=5 years (Scottish population – 82.9% urban, 11.21% 
accessible rural, 5.9% remote rural). P=0.04 for significant 
difference within GPA group. Category: series 1=urban; 
series 2=accessible rural; series 3=remote rural. AAV, ANCA- 
associated vasculitis; GPA, granulomatosis with polyangiitis; 
MPA, microscopic polyangiitis; PMP/year=per million 
population per year; error bars; SD.
Figure 2 Total number of patients with AAV on kidney 
biopsy by month (A) and season (B) across 5 years of the 
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of patients presenting with alarm symptoms.32 The socio-
cultural attitudes of rural dwellers imply they might delay 
seeking healthcare leading to severe disease at presenta-
tion.33 34
Studying the association between rurality and inci-
dence of a rare disease is challenging because, by defi-
nition, the background population in the rural areas is 
small. Scotland has a relatively high rural population, 
and our ability to include all diagnoses made through 
a 5- year period enhances the ability to detect a relevant 
association.
Our estimated incidence of kidney biopsy- proven AAV 
in Scotland (latitude 56oN) was 15.1 cases/million/year 
with a predominance of MPA (9.3 cases/million/year). 
This predominance of MPA over GPA in renal involve-
ment was also observed in Spain, Japan and Canada 
(Northern Saskatchewan), with latitudes 40oN, 36oN and 
55oN, respectively.29 35 36 In comparison with European 
regions with similar latitudes to Scotland, our results are 
at variance. In the Netherlands (latitude 52oN), GPA is 
twice as common as MPA in patients with AAV and renal 
involvement.37 Interestingly, a rise in ANCA titre during 
autumn was associated with a fourfold increased risk of 
relapse in patients with renal AAV.38 Sweden, similar lati-
tude to Scotland (latitude 60oN) had comparable inci-
dences of GPA and MPA with renal involvement.39
We found no association with seasonality, which 
differs from other published studies in AAV with or 
without renal involvement. European studies in primary 
systemic vasculitides suggest a trend towards an increase 
in GPA incidence during the winter. 40 41 One report 
from Spain demonstrated higher incidence of AAV with 
Table 2 Seasonality and disease activity in kidney biopsy- proven AAV, as measured by EGFR and proteinuria
MPA GPA
eGFR uPCR eGFR uPCR
Autumn 37.6±35.6 150 (76–233) 33.3±28.3 121 (40–451)
Winter 28.6±24.6 112 (76–290) 32.5±24.8 139 (104–176)
Spring 28.1±18.0 167 (101–392) 37.4±27.8 110 (69–190)
Summer 21.8±13.8 152 (77–326) 35.3±30.6 244 (115–281)
P value NS NS NS NS
Mean±SD values eGFR (mL/min/1.73 m2) and median (IQR) of urine protein:creatinine ratio (mg/mmol).
AAV, ANCA- associated vasculitis; eGFR, estimated glomerular filtration rate; GPA, granulomatosis polyangiitis; MPA, microscopic 
polyangiitis; UPCR, urine protein to creatinine ratio.












(95% CI) SIR (95% CI)
(A) Granulomatosis with polyangiitis
1 855 118 19 5.5 8 9.6 6.4 (4.0 to 8.8) 143 (94 to 207)
2 876 250 8 2.4 16 16.2 5.4 (3.2 to 7.5) 116 (74 to 173)
3 906 595 13 3.8 13 12.2 5.6 (3.4 to 7.7) 119 (77 to 174)
4 919 736 15 4.2 15 14.2 6.4 (4.1 to 8.7) 137 (92 to 196)












standardised rate (95% CI) SIR (95% CI)
1 855 118 11 3.2 21 25.2 8.0 (5.2 to 10.8) 74 (51 to 104)
2 876 250 17 5.0 29 29.4 10.3 (7.3 to 13.3) 96 (70.3 to 128)
3 906 595 17 4.9 19 17.8 7.7 (5.2 to 10.2) 71 (45 to 98)
4 919 736 17 4.8 23 21.8 8.5 (5.9 to 11.1) 79 (56 to 107)
5 931 084 17 4.7 34 32.4 10.8 (7.8 to 13.8) Ref
SIMD quintile of deprivation: Q1=most deprived, Q5=least deprived. Crude rate is number of cases in each quintile, adjusted for underlying 
age distribution within that quintile, per million population per year. Direct standardised rate=rate of disease within each quintile adjusted for 
overall Scottish age distribution. SIR = Standardised incidence ratio (95% confidence interval) for each quintile, compared with Q5 (reference 
group).
AAV, ANCA- associated vasculitis; GPA, granulomatosis polyangiitis; MPA, microscopic polyangiitis; SIMD, Scottish Index of Multiple 
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renal involvement during the winter.36 Fluctuation of 
seasonal incidence was noted primarily in GPA; however, 
this represented only 15% of cases in that cohort. The 
Spanish study was based on the onset of disease symp-
toms as opposed to the time of disease diagnosis. The 
preponderance of GPA in the winter has led to the 
hypothesis that a respiratory infection may trigger disease 
as a consequence of the higher incidence of viral infec-
tions in this season.7 On the contrary, a study of patients 
with GPA (80% had renal involvement) found preferen-
tial occurrence in the summer, thus suggesting a possible 
pathophysiological role of allergy.8 Case–control studies 
also support a history of allergy with systemic vasculitis.10 
We did not observe either summer or winter correlation 
in our Scottish renal AAV cohort.
In Miyazaki Prefecture, Japan where ethnic/genetic 
variation may play a role in disease incidence, MPA 
accounts for all ANCA- associated primary renal vascu-
litis.35 In this study, significant increase in incidence (rate 
ratio 3.67 (95% CI 1.49 to 9.03)) was observed in summer 
months (August–October) followed by months May–July 
(rate ratio 2.67 (95% CI 1.04 to 6.81)). This seasonal vari-
ation was not statistically different between urban and 
rural areas.
These inconsistencies suggest complex and potentially 
diverse environmental factors, influencing seasonal vari-
ation in different renal AAV cohorts. One such varia-
tion would include differences in sunlight exposure; UV 
radiation level has been shown to correlate with ANCA 
serotype.2 The climate in Scotland infers there is less vari-
ability in sunlight across seasons in contrast to Spain.
We initially hypothesised that seasonal variation could 
relate to external factors such as holiday periods. To 
explore this further, we included baseline kidney function 
and proteinuria in our analysis. We demonstrated similar 
levels of kidney dysfunction and proteinuria in newly 
diagnosed patients throughout the year, thus reducing 
the possibility of significant symptoms- to- diagnosis delay.
Previous studies have suggested an association between 
AAV and socioeconomic status. These studies are not 
limited to AAV with renal involvement. In New Zealand, 
the incidence of GPA was significantly lower in the two 
most deprived deciles compared with other deciles.14 Naz 
et al15 explored the relationship between socioeconomic 
factors and vasculitis in a UK pilot study using unemploy-
ment rate and self- reported health. Preliminary find-
ings did not show a clear trend between socioeconomic 
deprivation and the incidence of vasculitis. Recently, a 
Canadian study showed an association with lower socio-
economic deprivation and incidence of kidney biopsy- 
proven AAV.16 The study was set at a population level in 
British Columbia encompassing urban and rural areas. 
However, only income data were used as a measure of 
socioeconomic status. Socioeconomic deprivation is a 
complex construct, and a single measure of deprivation 
may not embrace the entirety of the effect on health.42 
We used a validated tool, the SIMD, including 38 domains 
that provide a multifaceted measure of socioeconomic 
deprivation. Analysing by quintiles of SIMD provides 
robust insight into relative socioeconomic deprivation. 
Furthermore, we accounted for the known differences 
in population age within deprivation quintiles by using 
age- standardised incidences. Using this tool, there was no 
discernible influence of deprivation on incidence of AAV.
While socioeconomic deprivation may not have an 
impact on disease incidence, it could be hypothesised 
that patients from areas of deprivation may present to 
health services later, as these patients often face barriers 
to healthcare, including access, referral pathway and lack 
of awareness of symptoms.43 We hypothesised that poorer 
kidney function at diagnosis would be associated with 
socioeconomic deprivation. In the UK, although health-
care is universal and free at the point of use, individuals 
living in more deprived areas are more likely to have 
severe CKD at presentation to renal services.44 However, 
in this study, we demonstrate that at the point of kidney 
biopsy for AAV, kidney function and proteinuria are 
comparable across quintiles of relative deprivation, 
implying that there is no significant delay in presentation 
to healthcare services. Universal healthcare is also avail-
able in British Columbia.16 In their population, kidney 
function and proteinuria were similar across socioeco-
nomic quintiles, supporting our findings. However, the 
level of kidney function at the time of biopsy was worse 
overall in comparison with our study.
Another crucial difference between the Canadian 
study and our analysis is that three racial groups (white, 
Chinese and South Asian) account for 90% of the popu-
lation in British Columbia. Fifty- four per cent of patients 
with biopsy- proven ANCA- related glomerulonephritis 
were white. Their results were not adjusted for race/
ethnicity. The population in Scotland is not racially 
diverse, with 96% identifying as white.45
Figure 3 MPA and GPA crude incidence rate per million 
population per year adjusted for age, separated by 
SIMD quintile and age group. GPA, granulomatosis with 
polyangiitis; MPA, microscopic polyangiitis; Q1, most 
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The strengths of our study lie in the ascertainment of a 
complete national cohort with renal biopsy- proven AAV 
in a national health service free at the point of access 
with no possibility that patients are diagnosed elsewhere 
such as the private sector. We used robust government 
data relating to geography and relative socioeconomic 
deprivation.
Considering seasonal variation, we focus on diagnosis 
date rather than the onset of symptoms, which could 
account for heterogeneity with other studies. AAV is a rare 
disease and, although our national cohort is larger rela-
tive to other published studies, it may yet be underpow-
ered to detect differences in seasonality and deprivation 
categories, particularly in the younger age category. Our 
data may not be generalisable to other countries, partic-
ularly with differing racial groups. The SIMD cannot 
be applied directly in other countries and provides a 
measure of relative rather than absolute deprivation.
Other limitations have to be considered. Our study 
population is limited to patients with kidney biopsy- 
proven AAV thus might not be representative of AAV in 
general.
There is the possibility a small number of patients 
with rapidly progressive glomerulonephritis or contra-
indications did not undergo biopsy and thus excluded 
in thiese data. Similarly, not all patients with AAV and 
renal involvement require kidney biopsy. This infers the 
association seen with GPA and rurality could be stronger 
or non- significant if all patients with AAV (renal and non- 
renal vasculitis) were included. We also did not investi-
gate rurality concerning age and gender given small case 
numbers in rural areas. AAV is more common in older 
adults, and the communities in rural Scotland are ageing 
faster than in cities.46
ANCA serology, which is explored in seasonality across 
other countries, is not presented in our data. However, 
patients with renal involvement are nearly always ANCA 
positive. A patient with suspected nephritis and positive 
ANCA serology has a >95% association of kidney histology 
findings relating to AAV.47
Concerning kidney pathology, biopsy findings were not 
classified according to the Berden48 histopathological 
classification; therefore, we are unable to make compar-
isons by subtype. We also cannot exclude the presence 
of coexisting antiglomerular basement membrane 
(anti- GBM) disease. Anti- GBM disease is likely to repre-
sent small numbers if occurring.
Our data suggest that further analysis of environ-
mental factors in rural areas is warranted to elucidate 
the aetiology and pathogenesis of GPA. It would also be 
of interest to study the impact of rurality and socioeco-
nomic deprivation on relapse rate, renal survival and 
patient survival in AAV.
This complete national dataset identifies a significant 
association between a diagnosis of renal GPA and living 
in a rural area. Contrary to previous studies, we did 
not observe seasonal variation in the incidence of AAV 
diagnosed on kidney biopsy. Additionally, there was no 
difference in the incidence of renal AAV across the spec-
trum of socioeconomic deprivation in Scotland. Under-
standing the influence of environmental factors in the 
incidence of renal AAV provides insight into underlying 
pathogenesis, informs and also directs health policy and 
resources.
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